These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 28150214)

  • 1. Exploiting Uptake of Nanoparticles by Phagocytes for Cancer Treatment.
    Sheen MR; Fiering S
    Methods Mol Biol; 2017; 1530():355-367. PubMed ID: 28150214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy.
    Toraya-Brown S; Sheen MR; Baird JR; Barry S; Demidenko E; Turk MJ; Hoopes PJ; Conejo-Garcia JR; Fiering S
    Integr Biol (Camb); 2013 Jan; 5(1):159-71. PubMed ID: 22935885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes.
    Lunov O; Syrovets T; Röcker C; Tron K; Nienhaus GU; Rasche V; Mailänder V; Landfester K; Simmet T
    Biomaterials; 2010 Dec; 31(34):9015-22. PubMed ID: 20739059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy.
    Choi JW; Park JW; Na Y; Jung SJ; Hwang JK; Choi D; Lee KG; Yun CO
    Biomaterials; 2015 Oct; 65():163-74. PubMed ID: 26164117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofluorescence of peritoneal phagocytes after infection of mice with L-cell-attenuated Chlamydia psittaci 6BC.
    Kordova N; Wilt JC; Shewchuk E; Meyer W
    Can J Microbiol; 1975 Jun; 21(6):759-63. PubMed ID: 1097065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels.
    Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C
    J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LyP-1-conjugated Fe
    Teo P; Wang X; Zhang J; Zhang H; Yang X; Huang Y; Tang J
    J Biomater Sci Polym Ed; 2018 Feb; 29(2):181-194. PubMed ID: 29165044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
    Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
    Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canagliflozin-loaded magnetic nanoparticles as potential treatment of hypoxic tumors in combination with radiotherapy.
    Angelopoulou A; Kolokithas-Ntoukas A; Papaioannou L; Kakazanis Z; Khoury N; Zoumpourlis V; Papatheodorou S; Kardamakis D; Bakandritsos A; Hatziantoniou S; Avgoustakis K
    Nanomedicine (Lond); 2018 Oct; 13(19):2435-2454. PubMed ID: 30311542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized iron oxide nanoparticles for controlling the movement of immune cells.
    White EE; Pai A; Weng Y; Suresh AK; Van Haute D; Pailevanian T; Alizadeh D; Hajimiri A; Badie B; Berlin JM
    Nanoscale; 2015 May; 7(17):7780-9. PubMed ID: 25848983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of custom-tailored iron oxide nanoparticles chemistry, uptake, and toxicity.
    Wilkinson K; Ekstrand-Hammarström B; Ahlinder L; Guldevall K; Pazik R; Kępiński L; Kvashnina KO; Butorin SM; Brismar H; Önfelt B; Österlund L; Seisenbaeva GA; Kessler VG
    Nanoscale; 2012 Dec; 4(23):7383-93. PubMed ID: 23070150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer.
    Zhang H; Li J; Hu Y; Shen M; Shi X; Zhang G
    J Ovarian Res; 2016 Mar; 9():19. PubMed ID: 27025582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
    Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
    Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.
    Amoozgar Z; Goldberg MS
    Adv Drug Deliv Rev; 2015 Aug; 91():38-51. PubMed ID: 25280471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.